// App-Quantinova.ai

SAT0231 (2018) : Effects of the jak1-selective inhibitor filgotinib on gene expression profile in blood of patients with active rheumatoid arthritis

Researchers

Presenter

  • P. C. Taylor

Principal Investigators

  • J. Tarrant

  • L. Zhao

  • Y. Gindin

  • A. Mirza

  • P. Harrison

  • C. Tasset

  • R. Galien

  • A. Van der Aa

  • B. Downie

Medical Centers

  • Botnar Research Centre Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences University of Oxford Oxford UK

  • Gilead Sciences, Inc., Foster City, CA, United States.

  • Galapagos, Mechelen, Belgium

  • Galapagos SASU, Romainville, France

Locations

  • United Kingdom

  • United States

  • Belgium

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Filgotinib

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved